An international team led by Emory scientists has gained insight into the pathological mechanisms behind two devastating neurodegenerative diseases. The scientists compared the most common inherited form of amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD) with a rarer disease called spinocerebellar ataxia type 36 (SCA36). Both of the diseases are caused by abnormally expanded and...
Tag: <span>collaborators</span>
Clinical trial in COVID-19 patients tests anti-inflammatory drug
by The Scripps Research Institute An anti-inflammatory drug developed at Scripps Research 25 years ago is now being tested as a way to prevent acute respiratory distress in patients with COVID-19, the pandemic disease caused by the novel coronavirus. The drug, a monoclonal antibody now owned by the pharmaceutical company Implicit Bioscience, is planned to...
Radboudumc researchers publish new insights into COVID-19
Researchers at the Radboud university medical center seem to have found an essential mechanism in the disease process of COVID-19, which has so far been overlooked. If the insight is correct, it probably has important consequences for the treatment of the disease. In an international collaborative effort it is now being investigated whether the new...
Scientists explore links between genetics, gut microbiome and memory
A new study is among the first to trace the molecular connections between genetics, the gut microbiome and memory in a mouse model bred to resemble the diversity of the human population. While tantalizing links between the gut microbiome and brain have previously been found, a team of researchers from two U.S. Department of Energy...
Sensitive 10 Minute Antibody Test for SARS-CoV-2 Developed
A team of researchers at the Southern Medical University, Guangzhou, China, and collaborators report development of a rapid diagnostic assay for detection of SARS-CoV-2 antibodies in human blood. They report accurate detection with patient samples, with only 10 minutes to get a readout per blood sample. The new method is a lateral flow assay, much...
New capsule can orally deliver drugs that usually have to be injected
Posted Today Many drugs, especially those made of proteins, cannot be taken orally because they are broken down in the gastrointestinal tract before they can take effect. One example is insulin, which patients with diabetes have to inject daily or even more frequently. In hopes of coming up with an alternative to those injections, MIT engineers, working with scientists from Novo Nordisk, have designed a new drug capsule that can carry...
- 1
- 2